FDA Inspection 1069228 — Xytex Laboratories

Xytex Laboratories — FEI 3003420280

The FDA completed an inspection of Xytex Laboratories on September 21, 2018 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 21, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Atlanta, GA (United States)